Efficacy and Safety of an Ophthalmic DMPC-Based Nanoemulsion in Patients with Dry Eye Disease: A Phase I/II Randomized Clinical Trial

Figure 1

Clinical study design. Phase I was a safety cohort and phase II was an expanded cohort for efficacy assessment.